Thales S.A. Q2 2026 Earnings Recap

Thales shares rose 4.2% post-results, reflecting investor approval of strong order inflows, solid organic sales growth, and notable margin expansion, driven by Defence and Aerospace segments.

Key Takeaways

• Order intake reached €12.5 billion, achieving 22% organic growth and maintaining a book-to-bill ratio above 1 at 1.14.
• Sales grew 7.8% organically to €10.9 billion, or 9.6% excluding the impact of two cancelled geostationary satellites.
• Adjusted EBIT increased 10% year-over-year to nearly €1.4 billion, supported by a €219 million gross margin expansion.
• R&D spending rose 9% to 6.2% of sales, while general & administrative expenses grew only 3%, illustrating disciplined cost management.
• Free operating cash flow reached €1.8 billion, close to three times the level of H1 2025, and net debt fell substantially by around €3 billion over 12 months.